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762Objective: Aged hearts are more vulnerable than mature hearts to reperfusion injury during cardiac surgery
because of altered cardiomyocyte Ca2þhomeostasis. Inasmuch as immature cardiomyocytes have similar prop-
erties, a specialized cardioplegic solution (del Nido cardioplegia) designed to protect children’s hearts may al-
so be beneficial for elderly patients. Our objective was to evaluate the ability of del Nido cardioplegic solution,
containing lidocaine and less Ca2þ than our standard cardioplegic solution, to protect aged cardiomyocytes
during cardioplegic arrest and reperfusion.
Methods:We used our novel isolated cell model of cardioplegic arrest and reperfusion to compare the effect of
del Nido cardioplegic solution with that of our standard cardioplegic solution on intracellular Ca2þ concentra-
tion, contractions, and membrane potential in cardiomyocytes from senescent rat hearts.
Results: The incidence of spontaneous contractions during cardioplegic arrest was lower with del Nido cardiople-
gia (3/11 vs 9/11 cells; P<.05) than with standard cardioplegia, and contractions could not be induced by field
stimulation of cardiomyocytes arrested with del Nido cardioplegia (0/11 vs 9/11 cells; P<.05). Intracellular di-
astolic Ca2þ levels were lower during arrest with del Nido cardioplegia (57.10  3.06 vs 76.19  3.45 nmol/L;
P<.05). During early reperfusion, a potentially injurious rapid recovery of intracellular Ca2þ associated with
hypercontraction in cardiomyocytes arrested with standard cardioplegic solution was avoided in cells treated
with del Nido cardioplegia (81.42  2.99 vs 103.15  4.25 nM; P<.05).
Conclusions: Del Nido cardioplegic solution has the potential to provide superior myocardial protection in
senescent hearts by preventing electromechanical activity during cardioplegic arrest and Ca2þ-induced hyper-
contraction during early reperfusion. (J Thorac Cardiovasc Surg 2011;141:762-70)Elderly patients undergoing cardiac surgery have a higher
risk of significant cardiac dysfunction and reduced survival
than do younger adult patients.1,2 One reason is that older
hearts are more susceptible to injury after periods of ische-
mia3,4 that occur during cardiac surgery. The mechanism
for this intolerance to ischemia in senescent myocardium
is related to changes in Ca2þ homeostasis resulting in intra-
cellular Ca2þ levels during ischemia that are higher and in-
crease at an accelerated rate.4-6 Myocardial injury after
ischemia is mediated in part by Ca2þ overload–induced hy-
percontracture during early reperfusion.7,8 Limiting accu-
mulation of intracellular Ca2þ during ischemia in aged
hearts does improve recovery of ventricular function.6
Cardioplegic solutions protect myocardium against is-
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The Journal of Thoracic and Cardiovascular Surgmixed with a crystalloid solution containing a high con-
centration of Kþ and depolarize the cardiomyocyte cell
membrane, thereby abolishing the generation and propaga-
tion of action potentials and the resulting contractions that
are responsible for most of the metabolic activity of the
heart.7,9 This slows the generation of intracellular acidosis
as a result of anaerobic metabolism during ischemia and
indirectly limits Ca2þ accumulation,7,10 thereby mitigating
myocardial injury on reperfusion. However, standard car-
dioplegic solutions do not control intracellular Ca2þ levels
as well in the aged myocardium,11 which correlates with
increased myocardial injury on reperfusion in aged
hearts.12
Immature hearts are also less tolerant to ischemia than is
mature myocardium.13 They are poorly equipped to deal
with postischemic Ca2þ overload14 and, therefore, are
more sensitive to Ca2þ-mediated injury during reperfusion.15
Strategies used in children to mitigate reperfusion injury in-
clude reducing Ca2þ in the cardioplegic solution and reper-
fusion with warm blood cardioplegic solution.15,16 Del
Nido cardioplegia is a pediatric cardioplegic solution that
has a low final Ca2þ content and contains an Naþ channel
blocker (lidocaine) that prevents Naþ and, indirectly, Ca2þ
accumulation in the cell during ischemia.17 We18 have found
that children undergoing heart surgery show evidence of less
myocardial damage when del Nido cardioplegia is used
instead of a standard cardioplegic solution.ery c March 2011
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MGiven that immature and senescent hearts are both suscep-
tible tomyocardial injuryowing to intracellularCa2þaccumu-
lation during ischemia, we investigated the possibility that
a cardioplegic solution designed specifically to protect young
myocardium (del Nido cardioplegia) may also have the po-
tential to provide better protection for aged myocardium.
MATERIALS AND METHODS
Animals
Experiments were performed in accordance with guidelines published
by the Canadian Council on Animal Care (CCAC; Ottawa, Ontario: Vol
1, 2nd edition, 1993; Vol 2, 1984). Aged male Fisher 344 rats (24 months)
were obtained from the National Institute on Aging (Baltimore, Md). An-
imals were maintained on a 12-hour light/dark cycle with free access to
food and water.
Cardiac Myocyte Isolation
Ventricular myocytes were obtained by enzymatic dissociation as de-
scribed previously.5 In brief, rats were heparinized (intraperitoneally,
3000 U/kg; Pharmaceutical Partners of Canada, Richmond, Ontario, Can-
ada) and anesthetized with sodium pentobarbital (intraperitoneally, 160
mg/kg; CDMV, Saint-Hyacinthe, Quebec, Canada). Hearts were cannu-
lated in situ through the aorta and perfused for 5 minutes (18 mL/min,
37C, gassed with O2) with buffer solution containing (mmol/L) 135.5
NaCl, 4 KCl, 10 HEPES, 1.2 MgSO4, 1.2 KH2PO4, 12 glucose, and 200
mmol/L CaCl2 (pH 7.4) to clear the heart of blood. The above solution with-
out CaCl2 was used to perfuse for an additional 5 minutes. This was fol-
lowed by an enzymatic digestion for 20 minutes by perfusion with
a buffer solution that contained 50 mmol/L CaCl2 supplemented with pro-
tease dispase II (Roche Diagnostics, Laval, Quebec, Canada; 0.14 mg/mL),
collagenase type 2 (270 U/mg, Worthington, Lakewood, NJ; 0.56 mg/mL),
and trypsin (Sigma–Aldrich, Oakville, Ontario, Canada; 0.02 mg/mL). Af-
ter perfusion with the enzyme solution, the ventricles were separated from
the atria andminced in high potassium substrate-enriched buffer containing
(mmol/L) 80 KOH, 30 KCl, 3 MgSO4.7 H2O, 30 KH2PO4, 50 L-glutamic
acid, 20 taurine, 0.5 ethylene glycol tetraacetic acid, 10 HEPES, and 10
glucose (pH 7.4with KOH). The supernatant was then decanted and filtered
through 225-mm polyethylene mesh to remove large cellular debris. Only
quiescent, rod-shaped cardiomyocytes with visible striations and no visible
membrane damage were used experimentally. No more than 2 ventricular
cardiomyocytes per heart were included in any data set.
Cardioplegic Arrest Model
Cardiomyocytes were incubated in a 0.75-mL chamber mounted on the
stage of an inverted microscope (Nikon ECLIPSE TE200; Nikon Canada,
Mississauga, Ontario, Canada). The cells were then superfused with Tyrode
solution containing (mmol/L) 129 NaCl, 20 NaHCO3, 0.9 NaH2PO4, 4 KCl,
0.5 MgSO4, 5.5 glucose, and 1.8 CaCl2 (pH 7.2; gassed with 95% O2 and
5% CO2). All experiments were conducted at 37
C. Buffer solutions were
heated to 37C with a custom-made heat exchanger and a circulating water
bath (Polystat Immersion Circulator; Cole Parmer Canada Inc, Anjou, Que-
bec, Canada). Superfusion with buffer was controlled by gravity to maintain
a flow rate of 6mL/min. The cellswere equilibrated in oxygenatedTyrode so-
lution for 10 to 20minutes and then superfusedwith buffer solutionsmodified
to approximate thefinal ionic concentrations of either delNidoor our standard
adult cardioplegic solutions as delivered in the clinical setting (Table 1).
In the clinical setting, a stock crystalloid solution is mixed with the pa-
tient’s blood in a ratio of 1:4 for the standard cardioplegia and a ratio of 4:1
for del Nido cardioplegia. Neither clinical solution contains added calcium,
but because of the different proportions of blood in the final preparation,
a significant difference in final calcium concentration between the 2
solutions exists. The cardioplegic solutions used for these in vitro studiesThe Journal of Thoracic and Cacontained no blood components. The cardioplegic solutions were bubbled
with 90% N2 and 10% CO2 and this gas was directed over the chamber to
induce ischemia during cardioplegic arrest. After a 30-minute cardioplegic
arrest period, cardiomyocytes were reperfused with oxygenated Tyrode so-
lution for an additional 30 minutes. Myocytes were field stimulated at 4 Hz
with 3-ms pulses delivered via a pair of platinum electrodes. Current
stimulus and duration were controlled by Clampex 8.2 software (Molecular
Devices, Sunnyvale, Calif) and an SIU-102 stimulus isolation unit (Warner
Instruments, Hamden, Conn). Field stimulation was interrupted during
cardioplegic arrest, except for brief periods at 12 and 22 minutes after
the start of cardioplegia to check for cardiomyocyte excitability. Simulta-
neous recordings of contractions and intracellular calcium levels were
made at regular intervals before, during, and after cardioplegic arrest as
described below for a total of 65 minutes; responses remained stable for
this length of time, as shown previously.5
Measurement of Cardiomyocyte Contractions
Unloaded cell shortening was measured with a video edge detector
(model 105; Crescent Electronics, Sandy, Utah), coupled to a video camera
on the microscope. Cell length and fluorescence were simultaneously
recorded from each cell by splitting the microscope light with a dichroic
cube. The video edge detector received red light, and remaining light was
sent to the photomultiplier tube for fluorescence measurements
(described below). Axoscope 8.2 (Molecular Devices) was used to record
contractions. Ten-second recordings were taken every 5 minutes (with
additional recordings at 12 and 22 minutes after induction of cardioplegic
arrest and at 1 and 2 minutes after the beginning of reperfusion). Analog
signals were converted to digital signals through a Digidata 1322A A/D
board (Molecular Devices). Trains of contractions were averaged and mea-
sured with Clampfit 8.2 software (Molecular Devices). Contraction ampli-
tudewas defined as the difference between systolic and diastolic cell length.
Measurement of Intracellular Ca2þ
Cells were loaded with the Ca2þ-sensitive dye fura-2 AM (5 mmol/L,
15 minutes, room temperature; Invitrogen, Burlington, Ontario, Canada),
and intracellular Ca2þ was measured by whole cell photometry (Del-
taRAM, Photon Technology International, Evansville, Ind). The emission
ratio at 510 nm, during alternate excitation at 340 nm and 380 nm, was
used to determine intracellular Ca2þ concentrations. Background fluores-
cence values were determined at each excitation wavelength. These back-
ground values were subtracted from the recordings made at each
wavelength during each experiment. Emission ratios were converted to in-
tracellular Ca2þ concentrations with an in vitro calibration curve. Felix32
software (Photon Technology International) was used to record data.
Ca2þ transient amplitudes were the difference between systolic and dia-
stolic Ca2þ. Ca2þ concentrations were recorded for approximately 10 sec-
onds. Trains of Ca2þ transients were averaged and peak responses were
measured with Clampfit 8.2 software (Molecular Devices).
Intracellular Recordings
Some cardiomyocytes were impaled with glass microelectrodes (30 mol/
LU, filled with 2.7 mol/L KCl) for simultaneous recording of membrane
potential and unloaded cell shortening (as described earlier). Membrane po-
tential was recorded with an Axoclamp 2B amplifier (Molecular Devices).
Action potentials were initiated by injection of 3-ms current pulses
(3–4 nA) at a frequency of 4 Hz. Myocytes were stimulated in this manner
under control conditions (before cardioplegia) and at various times during
cardioplegic arrest with either del Nido or standard cardioplegia (Table 1).
Resting membrane potential was measured with Clampfit 8.2 software.
Statistical Analysis
Data are presented as mean  SEM. Tests for statistical significance in-
cluded 2-way analysis of variance with post hoc comparisons byrdiovascular Surgery c Volume 141, Number 3 763
TABLE 1. Composition and final ion concentration of cardioplegic
solutions
Standard
cardioplegia
Pediatric (del Nido)
cardioplegia
Composition (mmol/L)
Na gluconate 18.46 17.33
Na acetate — 20.34
NaHCO3 33.3 13.79
NaCl 83.52 91.66
NaH2PO4 0.72 0.18
MgSO4 4.61 6.18
MgCl2 — 1.13
KCl 18.42 24.3
CaCl2 1.0 0.24
Glucose 4.4 1.1
Lidocaine — 0.36
Mannitol — 13.72
Ionic concentration (mmol/L)
Naþ 136 143.3
Kþ 18.42 24.3
Mgþ 4.61 7.31
Caþþ 1.0 0.24
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MStudent–Newman–Keuls method only when the analysis of variance yielded
a significantPvalue, unpaired t test, andFisher’s exact testwhere appropriate.RESULTS
Del Nido Cardioplegia Causes Larger Membrane
Depolarization Than Standard Cardioplegia
To evaluate the impact of standard and del Nido cardiople-
gia on membrane potential, we took intracellular recordings
under control conditions (before cardioplegic arrest)
and during cardioplegic arrest. There was a more pro-
nounced resting membrane potential depolarization with
del Nido cardioplegia than with standard cardioplegia
(36.5  1.7 vs 22.3  3.2 mV; P ¼ .018; n ¼ 3/group),
but baseline values were not significantly different (77  3
vs70  3 mV).Del Nido Cardioplegia Reduces Spontaneous and
Inducible Activity During Arrest
To determine the relative ability of our standard cardio-
plegia and del Nido cardioplegia to induce and maintain ar-
rest in aged cardiomyocytes, we examined the recordings of
Ca2þ transients and contractions made during the cardiople-
gic period. We observed spontaneous slow, low-amplitude
Ca2þ transients associated with contractions in some cells
despite the administration of either cardioplegic solution
(Figure 1, A). However, a substantially lower proportion of
cells showed spontaneous Ca2þ transients during cardiople-
gic arrest with del Nido cardioplegia when compared with
those arrested with standard cardioplegia (Figure 1, B).
This was associated with a corresponding reduction in the
proportion of cardiomyocytes exhibiting spontaneous764 The Journal of Thoracic and Cardiovascular Surgcontractile activity (Figure 1, C). We also examined induc-
ible activity during cardioplegic arrest by attempting to elec-
trically stimulate the cells 12 and 22 minutes into the
ischemic period (Figure 2, A). Ca2þ transients (Figure 2, B)
and contractions (Figure 2, C) could be induced in approxi-
mately 80% of cells arrested with standard cardioplegia but
not in any of the cells arrested with del Nido cardioplegia.
Del Nido Cardioplegia Reduces Intracellular Ca2þ
Levels During Arrest and Reperfusion
The ability of our standard cardioplegia and del Nido car-
dioplegia to prevent intracellular Ca2þaccumulation during
ischemic cardioplegic arrest and reperfusion was evaluated
by comparing diastolic Ca2þ levels during these times
(Figure 3). Both cardioplegic solutions prevented an accu-
mulation of intracellular Ca2þduring ischemic cardioplegic
arrest (Figure 3, A). However, intracellular diastolic Ca2þ
levels were lower during arrest in cardiomyocytes treated
with del Nido cardioplegia than in to those treated with stan-
dard cardioplegia (Figure 3, B). Perhaps most important, in-
tracellular diastolic Ca2þ levels also remained lower during
the critical early reperfusion period in cells arrested with del
Nido cardioplegia than in those arrested with standard car-
dioplegia (Figure 3,C). These differences were apparent de-
spite the fact that the reperfusion buffer was identical in
each group (oxygenated Tyrode solution). We also exam-
ined recordings of the induced Ca2þ transients under control
conditions (before cardioplegic arrest), during cardioplegia,
and during reperfusion (Figure 4, A). Calcium transients
could only be induced during the cardioplegic period in
cells arrested with the standard cardioplegia (Figure 4, A,
upper panel). However, Ca2þ transients returned in both
groups on reperfusion. The magnitude of the Ca2þtransients
was similar in both groups during reperfusion (Figure 4, B).
Del Nido Cardioplegia Prevents Hypercontraction
During Early Reperfusion
We evaluated the contractile state of cardiomyocytes un-
der control conditions (before cardioplegic arrest), during
cardioplegia, and during reperfusion after cardioplegic ar-
rest with either standard or del Nido cardioplegia by exam-
ining recordings of unloaded cell shortening (Figure 5, A).
In cardiomyocytes arrested with standard cardioplegia,
there was a rapid increase in contraction amplitude beyond
baseline values during the critical early reperfusion period
(Figure 5, B). However, in cardiomyocytes arrested with
del Nido cardioplegia, contraction amplitude during early
reperfusion was significantly lower and return to baseline
was delayed (Figure 5, B). We also looked for evidence of
hypercontracture during ischemia and reperfusion by exam-
ining diastolic cell length under control conditions (before
cardioplegic arrest), during cardioplegia, and during reper-
fusion (Figure 5, C). There appeared to be a minor decrease
in diastolic cell length during early reperfusion that was notery c March 2011
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FIGURE 1. Analysis of spontaneous activity in cardiomyocytes during cardioplegic arrest. A, Representative tracings of spontaneous Ca2þ transients (upper
panel) and cell length (lower panel) from cardiomyocytes during cardioplegic arrest. B, Bar graph representing the percentage of cardiomyoctes showing
spontaneous Ca2þ transients during arrest with either standard or del Nido cardioplegia. C, Bar graph representing the percentage of cardiomyocytes showing
spontaneous contractions with each cardioplegic solution. Total of 11 cells per group; *P<.05.
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Mstatistically significant and was not different between cells
treated with standard or del Nido cardioplegia (Figure 5,C).DISCUSSION
The unique characteristics of aged myocardium that
make older hearts susceptible to Ca2þ-mediated ischemia–
reperfusion–induced dysfunction after heart surgery sug-
gest that a tailored myocardial preservation strategy could
improve outcomes for this ever-expanding group of pa-
tients. Our results indicate that a cardioplegic solution de-
signed to limit intracellular Ca2þ in immature myocardium
may also be effective in senescent hearts.
We have demonstrated that del Nido cardioplegia is more
effective than our standard cardioplegia at eliminating both
spontaneous and inducible increases in intracellular Ca2þ
and contractions in isolated aged cardiomyocytes during is-
chemic arrest. Eliminating this metabolic activity is ex-
pected to minimize the energy requirements, thereby
delaying the development of intracellular acidosis as a result
of anaerobic metabolism. Intracellular acidosis is a main
driver of increased cytoplasmic Ca2þ levels during ischemia
by promoting Naþ influx through the Naþ/Hþexchanger and
Naþ/HCO3 symporter, which in turn causes Ca
2þ influx
through reverse mode Naþ/Ca2þ exchange.8 Elevated intra-The Journal of Thoracic and Cacellular Ca2þ is a major effecter of cardiomyocyte damage
resulting from ischemia–reperfusion injury.7,8 It is therefore
possible that more effective elimination of spontaneous and
inducible activity seen at the cellular level with del Nido
cardioplegia could translate into reduced ischemia–
reperfusion injury and improved heart function and
therefore better outcomes after cardiac surgery in elderly
patients.
Inducible activity is completely eliminated in cardio-
myocytes arrested with del Nido cardioplegia. Two charac-
teristics of del Nido cardioplegia possibly responsible for
this observation are (1) higher Kþconcentrations that result
in more pronounced membrane depolarization, which may
be more effective at inactivating the voltage-dependent fast
Naþ channels responsible for action potential generation,
and (2) the presence of lidocaine that blocks fast Naþchan-
nels, which may further prevent action potential generation.
These 2 factors are synergistic because Naþ-channel block-
ade by lidocaine is voltage sensitive and therefore enhanced
in the setting of membrane depolarization.19
We observed spontaneous Ca2þ transients associated
with contractions in cells from both cardioplegia groups.
Spontaneous Ca2þ release from the sarcoplasmic reticulum
does occur, particularly in the setting of Ca2þ overload.20rdiovascular Surgery c Volume 141, Number 3 765
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FIGURE 2. Analysis of inducible activity in cardiomyocytes field-stimulated during cardioplegic arrest. A, Representative tracings of Ca2þ transients (upper
panels) and cell length (lower panels) from cardiomyocytes arrested with either standard or del Nido cardioplegia.Marker represents timing of the field stim-
ulus. B, Bar graph representing the percentage of cardiomyocytes showing Ca2þ transients induced by field stimulation during arrest with each cardioplegic
solution. C, Bar graph representing the percentage of cardiomyocytes showing contractions induced by field stimulation during arrest with each cardioplegic
solution. Total of 11 cells per group; *P<.05.
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MThe incidence of spontaneous Ca2þ transients and contrac-
tions is lower in cells treated with del Nido cardioplegia,
which may be related to lower diastolic Ca2þ levels seen dur-
ing ischemic arrest in this group of cells. Lower cytoplasmic
Ca2þ concentrations could result in lower sarcoplasmic
reticulum Ca2þ loading and therefore fewer spontaneous
Ca2þ releases in cardiomyocytes arrested with del Nido
cardioplegia.
In models of ischemia and reperfusion without cardiople-
gic arrest, a progressive increase in intracellular Ca2þ asso-
ciated with contracture develops during the ischemic
period.7,8 In contrast, we found low and gradually declining
intracellular Ca2þ levels in cardiomyocytes arrested with
cardioplegia during a 30-minute ischemic period. There
are at least 3 factors likely responsible for this difference:
(1) Eliminating electromechanical activity with cardiople-
gia minimizes anaerobic metabolism and the development
of intracellular acidosis responsible for driving intracellular
Ca2þaccumulation; (2) prolonged availability of adenosine
triphosphate during ischemia as a result of the reduced met-
abolic rate may allow ongoing uptake of cytoplasmic766 The Journal of Thoracic and Cardiovascular SurgCa2þ by the sarcoplasmic reticulum; (3) the cardioplegic
solutions have low Ca2þ concentrations that would reduce
the concentration gradient favoring movement of Ca2þ
into the cell. Even though Ca2þaccumulation does not occur
with either cardioplegic solution, intracellular Ca2þconcen-
trations are lowest with del Nido cardioplegia. This may be
due to a lower Ca2þ concentration in del Nido cardioplegia
than in the standard cardioplegia. Lidocaine present in del
Nido cardioplegic solution may block the inward Naþ‘‘win-
dow’’ current that is active across the depolarized mem-
brane,21,22 thereby preventing reverse mode Naþ/Ca2þ
exchange leading to Ca2þ influx.
Early reperfusion is a critical phase in the pathogenesis of
ischemia–reperfusion injury. Excessive force generation
during this period can lead to cell damage and/or death.8
This process typically manifests as Ca2þ-induced hypercon-
tracture resulting from restored availability of adenosine tri-
phosphate to the contractile apparatus in the presence of
elevated intracellular Ca2þlevels.8We do not see true hyper-
contracture in our model because cardioplegic arrest pre-
vents development of the elevated intracellular Ca2þ levelsery c March 2011
Time (min)
0 10 20 30 40 50 60
D
ia
st
ol
ic
 C
a2
+  
(nM
)
0
50
100
150
del Nido
Standard
D
ia
st
o
lic
 C
a2
+  
(nM
) in
 
a
rr
e
st
0
50
100
*
D
ia
st
o
lic
 C
a2
+  
(nM
) in
 re
pe
rfu
si
on
0
50
100
*
Standard
del Nido
Cardioplegic
arrest
Standard
del Nido
FIGURE 3. Analysis of diastolic Ca2þlevels during cardioplegic arrest and reperfusion.A, Graph showing diastolic Ca2þlevelsmeasured in cardiomyocytes at
several time points immediately before, during, and after 30 minutes of ischemic cardioplegic arrest with either standard or del Nido cardioplegic solution.
Dashed line represents mean baseline value. B, Bar graph representing average diastolic Ca2þ levels during arrest with each cardioplegic solution. C, Bar graph
representing average diastolic Ca2þ levels during reperfusion after arrest with each cardioplegic solution.Data points and bars represent mean SEM; n¼ 11
cells per group; *P<.05.
O’Blenes et al Perioperative Management
P
Mduring ischemia that are responsible for this phenomenon.
Despite this fact, we do see differences in the magnitude
of contractions of our isolated cardiomyocytes during early
reperfusion, depending on which cardioplegic solution was
used. In cells treated with standard cardioplegia, we see
rapid return of contraction amplitude beyond baseline
values. In contrast, recovery of contractions to baseline
values was more gradual after arrest with del Nido cardio-
plegia.Wepropose that even in the absence of significant hy-
percontracture, suppressing contractions during early
reperfusion may still be beneficial in postischemic cardio-
myocytes that appear to have a cytoskeleton that is fragile
and unable to resist large contraction forces.8 The delay in
the return of diastolic Ca2þ levels and contraction amplitude
toward baseline values in aged cardiomyocytes arrestedwith
del Nido cardioplegic solution may simply be related to the
lower intracellular Ca2þlevels in these cells at the beginning
of the ischemic period. However, residual lidocaine block-
ade of Naþchannels during early reperfusion may also result
in less Ca2þ influx or reduce contractility by shorteningThe Journal of Thoracic and Caaction potential duration independent of intracellular Ca2þ
levels.23 The differences in contractions we see between
the 2 cardioplegic solutions correlates with diastolic Ca2þ
levels rather than the magnitude of the Ca2þ transient. This
is consistent with our previous report that the degree of
cell shortening increases with diastolic Ca2þlevels indepen-
dent of a change in the Ca2þ transient.24
Limitations
This study focused on intracellular events during simu-
lated cardioplegic arrest and reperfusion in an experimental
system, the limitations of which must be considered when
assessing the clinical implications of our results. We used
senescent rat cardiomyocytes as a model of aged human
myocardium. Although aged rodents are a practical model,
information about the generalizability of conclusions from
these models is limited. However, many age-associated
changes in cardiac structure and function seen in humans
are also observed in rodent models.3,4,25 In the clinical sit-
uation, the cardioplegic solutions we studied are usuallyrdiovascular Surgery c Volume 141, Number 3 767
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Mmixed with blood and delivered cold on an intermittent ba-
sis. It was not possible to include these conditions in our
model. However, the cardioplegic solutions were formu-
lated to mimic the ionic composition that would be found
in the clinical solutions once mixed with blood. The solu-
tions did not contain blood cells or proteins, which could
have an impact on the results. Although it is true that car-
dioplegic solution is usually delivered cold, the presence of
coronary artery disease and collateral flow can result in in-
complete cooling of the myocardium and rewarming be-
tween doses. We propose that inadequately cooled768 The Journal of Thoracic and Cardiovascular Surgmyocardium may be susceptible to the type of spontaneous
and inducible electromechanical activity that is prevented
by del Nido cardioplegia. Although our cells were perfused
continually during the experiment, the cardioplegic solu-
tions were rendered hypoxic in an attempt to model the is-
chemic period that occurs between doses of cardioplegic
solution clinically.
CONCLUSIONS
We have demonstrated that arrest with del Nido cardio-
plegia results in lower spontaneous and inducible activityery c March 2011
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cyte and measured at several time points before, during, and after 30 minutes of ischemic cardioplegic arrest with either standard or del Nido cardioplegic
solution. Dashed line represents the mean baseline value. C, Graph showing diastolic cell length measured at several time points before, during, and after
cardioplegic arrest. Data points represent mean  SEM; n ¼ 11 cells per group.
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Mduring the ischemic period, lower diastolic Ca2þ during is-
chemia and reperfusion, and gradual return of contraction
amplitude during early reperfusion in aged cardiomyocytes
when compared with standard cardioplegia. Isolated heart
and whole animal preclinical studies will be required to de-
termine whether the beneficial effects seen during ischemia
and early reperfusion translate into improved cardiac func-
tion. Del Nido cardioplegia may have a place alongside
other strategies, such as warm reperfusion, in a tailored ap-
proach to myocardial protection in the elderly.
We thank Peter Nicholl for his technical support.
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